Sativex receives regulatory authorisation in Spain

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex receives regulatory authorisation in Spain

Postby MSUK » Wed Jul 28, 2010 7:43 am


Almirall, S.A. and GW Pharmaceuticals plc today announced that the health authorities in Spain have granted regulatory approval for Sativex® Oromucosal Spray as an add-on therapy for the treatment of moderate to severe spasticity due to Multiple Sclerosis (MS) in patients who have not responded adequately to other anti-spasticity medication.

Prior to launch, Sativex® requires pricing and reimbursement approval from the Spanish Ministry of Health. This final approval process is expected to be completed during the 4th Quarter of 2010... Read More - ... ageid/1814
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Sativex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service